Gut microbiota dysbiosis and its relation to osteoporosis and sarcopenia in older people
Gut microbiome remains a very promising therapeutic target against osteoporosis and sarcopenia, but no recommendations can be made for clinical practice at the current state-of-art. Microbiome-targeted strategies may soon emerge as valuable adjuvant therapies in the management of age-related musculoskeletal decline.
Authors
- Stefano Volpato (ORCID: https://orcid.org/0000-0003-4335-6034)
- Andrea Ticinesi (ORCID: https://orcid.org/0000-0001-9171-8592)
- Riccardo Spaggiari (ORCID: https://orcid.org/0000-0001-6069-7514)
- Angelina Passaro (ORCID: https://orcid.org/0000-0001-8462-7000)
Institutions
- University of Parma (IT)
- University of Ferrara (IT)
- Arcispedale Sant'Anna (IT)
Publication Details
- Journal
- Current Opinion in Clinical Nutrition & Metabolic Care
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1097/mco.0000000000001173
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00